The University of Saskatchewan is a Canadian public research university, founded on March 19, 1907, and located on the east side of the South Saskatchewan River in Saskatoon, Saskatchewan, Canada.

During the past decade, University of Saskatchewan conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 2 clinical trials were completed, i.e. on average, 3.8% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 1 clinical trials were completed. i.e. 3.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Saskatchewan" #1 sponsor was "University of Saskatchewan" with 55 trials, followed by "Human Genome Sciences Inc." with 2 trials sponsored, "Jason Andrade" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "University of Alberta" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Saskatchewan" #1 collaborator was "Saskatchewan Health Research Foundation" with 8 trials as a collaborator, "Royal University Hospital Foundation" with 5 trials as a collaborator, "Heart and Stroke Foundation of Canada" with 4 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator and "Saskatchewan Centre for Patient-Oriented Research" with 3 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "University of Saskatchewan" are "Asthma" (12 trials), "Osteoporosis" (4 trials), "Atrial Fibrillation" (3 trials), "Sarcopenia" (3 trials) and "COPD" (2 trials). Many other conditions were trialed in "University of Saskatchewan" in a lesser frequency.

Most popular intervention types in "University of Saskatchewan" are "Drug" (26 trials), "Other" (21 trials), "Behavioral" (14 trials), "Dietary Supplement" (11 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Albuferon" (2 trials), "No Intervention" (2 trials), "Ribavirin" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Saskatchewan" are 77 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are 25 active trials in "University of Saskatchewan". 2 are not yet recruiting, 18 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 51 completed trials in University of Saskatchewan, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Saskatchewan, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 48 trials that are defined as “Not Applicable".

University of Saskatchewan has several departments that took part in Clinical trials: "College of Kinesiology, University of Saskatchewan" - 15 trials, "University of Saskatchewan Department of Psychiatry" - 2 trials, "c/o Hemodynamics Offices" - 2 trials, "Rheumatology Associates of Saskatoon" - 2 trials, "Ob-Gyn Royal University Hospital" - 2 trials